click to access course materials from past events

click to upload a file to Camenae Group

Course Detail

Cardiovascular Symposium 2013

Baylor Jack and Jane Hamilton Heart and Vascular Hospital and The Camenae Group have banded together to form the CS Crusaders, an extraordinary group of leaders and heroes that share a common goal - the eradication of the multi-faced villain known collectively as Cardiovascular Disease.  This formidable group of super heroes will share their tactics and intel on the high priority issues and latest clinical advances in the battle against this brutal enemy at a top-secret gathering on August 17th, 2013. 

Your commitment in the battle against Cardiovascular Disease has not gone unnoticed.  And so, it is a great honor to for us to be able to extend this invitation imploring you to join forces with us at this, the 17th Annual Cardiovascular Symposium. But be warned - time is short and the fate of all mankind may well lie in your hands. Should you choose to accept this mission and join our rapidly growing roster of heroes, register now by selecting the register online link on this page. 

THE MISSION

7:15 AM
Registration and Continental Breakfast 
7:50

MISSION BRIEFING
Welcome and Program Overview
Captain Cardio
8:00

COVERT INFILTRATION TACTICS
Dialysis 101:  Strategies, Indications & Complications of Dialysis Access
Stephen Hohmann, MD
9:00

GOING ULTRASONIC
Renal Denervation Therapy for Severe Hypertension:  The Simplicity Trial Data
James Choi, MD
10:00
Break and Exhibits
10:30

THE LAB - SUPERPOWER HOTSPOT
Evaluation of Aortic and Mitral Valve Disease in the Cath Lab
Ravi Vallabhan, MD
11:30
Lunch/Exhibits
1:00 PM

GONZO’S  GADGETS
Devices to Bridge to Transplant
Gonzo Gonzalez, MD
2:00
Break and Exhibits 
2:20

BAM! POW! ZAP!
Re-Energizing Nursing Interventions for Heart Failure Patients
Sarah Simmons, BSN, CCRN + Jacie Edelstein, BSN, BA, CCRN +  Cetty Abraham, BSN, CCRN
3:20

THE X CELLS
Stem Cell Therapy for Cardiovascular Disease
Cara East, MD
4:20
Q&A, Closing Remarks, and Evaluation

THE OBJECTIVES
At the conclusion of this activity, superhero participants will be able to:

  • Examine the pathophysiological background for renal sympathetic denervation.
  • Summarize the role of renal sympathetic innervation in past and present interventional approaches for the treatment of hypertension.
  • Define the pathogenesis of hypertension and its effects on the kidney.
  • Appraise the available and under development mechanical therapies for end-stage congestive heart failure.
  • Analyze clinical guidelines for LVADs as a bridge to cardiac transplantation versus destination therapy.
  • Describe current techniques in evaluating aortic and mitral valve disease in the cardiac cath lab.
  • Examine aortic and mitral valve disease and its effect on the heart.
  • Evaluate and discuss patients who qualify for dialysis.
  • Discuss the etiology and current pharmacological treatments in heart failure.
  • Define stem cell therapy and its use in cardiovascular disease.

THE CS CRUSADERS

James W. Choi, MD, FACC, FSCAI
Clinical, Nuclear and Interventional Cardiologist
Baylor Heart and Vascular Hospital

Cara East, MD, FACP
Internal Medicine, Cardiology and Research
Baylor Heart and Vascular Hospital

Gonzo Gonzalez, MD
Thoracic Surgeon
Baylor Heart and Vascular Hospital


 

Stephen Hohmann, MD, FACS
Vascular Surgeon
Baylor Heart and Vascular Hospital

Ravi C. Vallabhan, MD, FACC, FSCAI
Interventional Cardiologist
Baylor Heart and Vascular Hospital

And Featuring the Amazing...
LEGION OF ScUPER NURSES
Sarah Simmons, BSN, CCRN
Jacie Edelstein, BSN, BA, CCRN
Cetty Abraham, BSN, CCRN

THE CREDIT
Accreditation Statements 

NURSING
The Camenae Group, Inc. is an approved provider of continuing nursing education by the Texas Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity provides up to 6.0 Nursing Contact Hours.

RADIOLOGIC TECHNOLOGIST
This activity is approved for credit by the ASRT (7.0 Category A Credits - Indirect).

SONOGRAPHER
This activity has been approved for 6.0 SDMS CME Credits.

RESPIRATORY THERAPISTS
This program has been approved for 6.00 contact hours Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd. Suite 100 Irving TX 75063.

Course # 140758000

TO JOIN IN THE FRAY...
Register online by clicking the button above - or CLICK HERE.
We encourage you to utilize the online registration -  it is the most efficient and produces the least registration errors.  You may also print and complete registration form and return to the Camenae Group by fax (817.377.3991) or mail (CS2013 - C/O Camenae Group, 2665 Johnson Road, Southlake, TX 76092).
Space is limited and early registration is advised. Availability of on-site registrationis not guaranteed. Tuition includes online course syllabus, continental breakfast, lunch, and refreshment break. All registrations will be acknowledged by email -  you must provide a valid email in order to receive your registration acknowledgement. A $25 service charge will be added to each returned check and/or credit/debit card denial.
Preregistration Due Date: To qualify for the preregistration rate, registration and payment must be received by August 12, 2013.
Cancellation Policy: Cancellations accepted until 5:00 PM CST, August 12, 2013, subject to a $10 admin fee. No refunds will be given after that date, but substitutions will be accepted. No-shows are not eligible for a refund. All preregistered, unpaid no-shows will be billed for the full tuition.

 

Healthcare Professionals $99
Baylor Healthcare Professionals $89

Group Discounts are available for groups of 6 or more registrants.  Please email info@camenaegroup.com to request a group discount code.

ACKNOWLEDGEMENTS

Special thanks to the following exhibitors for their participation in this activity:

Abbott Vascular
Medtronic

Abiomed
Arrow Cardiac Care
Boehringer-Ingelheim
Cordis
Covidien

Gilead Sciences
Infinity Medical Associates
Lippincott Williams & Wilkins
Philips

The Medicines Company
Volcano Corporation